Entheon Biomedial and MVP Exploration Logos

Entheon and MPV announce amalgamation

Entheon Biomedical and MPV Exploration have executed a definitive agreement, whereby MPV Exploration will acquire all the issued and outstanding shares of Entheon pursuant of a 3 cornered amalgamation.

Click here to read the full press release

Get the latest investor updates delivered to your inbox.

Please provide your phone number to receive a call from our business development team.

Please check the box above to subscribe to our investor releases

Who we are

Entheon Biomedical is a biotechnology company committed to the development of safe & effective psychedelic medicines in order to provide patients with access to evidence-based treatments for addiction disorders.

Visit Entheon's website
Visit MPV's Website